Descriptor

Total Cohort (n = 207)

Positive outcome (n = 186)

Poor outcome (n = 21)

P

Age groups in years

65 - 74

57 (27.5)

54 (29)

3 (14.3)

0.152

75 - 84

86 (41.5)

78 (41.9)

8 (38.1)

0.735

≥85

64 (31)

54 (29)

10 (47.6)

0.081

Gender

Male

82 (39.6)

72 (38.7)

10 (47.6)

0.429

Female

125 (60.4)

114 (61.3)

11 (52.4)

Admitted from NH

32 (15.5)

31 (16.7)

1 (4.8)

0.153

# comorbidities/patient

3 (2 - 4)

3 (2 - 4)

4 (3 - 4)

0.001

Specific comorbidity

Hypertension

182 (87.9)

164 (88.2)

18 (85.7)

0.743

Diabetes mellitus

68 (32.9)

58 (31.2)

10 (47.6)

0.128

Coronary artery disease

61 (29.5)

53 (28.5)

8 (38.1)

0.360

Atrial fibrillation

50 (24.2)

40 (21.5)

10 (47.6)

0.008

Congestive heart failure

38 (18.4)

31 (16.7)

7 (33.3)

0.061

Chronic obstructive pulmonary disorder

19 (9.2)

15 (8.1)

4 (19)

0.098

Renal failure/chronic kidney disease

18 (8.7)

12 (6.5)

6 (28.6)

0.001

History of stroke

29 (14.0)

21 (11.3)

8 (38.1)

0.001

Dementia

85 (41.1)

79 (42.5)

6 (28.6)

0.220

Injury Severity Score

16 (9 - 16)

16 (9 - 16)

16 (16 - 20)

<0.001

Mechanism of injury

Fall

198 (95.7)

177 (95.2)

21 (100)

0.588

Motor vehicle crash

8 (3.9)

8 (4.3)

--

Assault

1 (0.5)

1 (0.5)

--

Admit vitals

HR

80 (70 - 88)

80 (71 - 88)

84 (65 - 93)

0.822

BT (˚F)

98.1 (97.8 - 98.5)

98.2 (97.9 - 98.5)

97.9 (97.6 - 98.3)

0.125

SBP

143 (129 - 161)

143 (131 - 161)

139 (117 - 170)

0.280

RR

18 (16 - 20)

18 (16 - 19)

18 (15 - 19)

0.182

GCS

15 (15 - 15)

15 (15 - 15)

14 (14 - 15)

<0.001

Home antithrombotic

None

87 (42.0)

84 (45.2)

3 (14.3)

0.007

Antiplatelet

81 (39.1)

70 (37.6)

11 (52.4)

0.189